Mawer Investment Management Divests Entire Organon Stake

TL;DR

**Mawer just dumped all its Organon shares, watch out!**

AI Summary

Mawer Investment Management Ltd., a Canadian investment firm, filed an amendment to its Schedule 13G on February 5, 2024, indicating that as of December 31, 2023, it no longer beneficially owns any shares of Organon & Co. This update shows a complete divestment from the pharmaceutical company, as Mawer now holds 0 shares with both sole and shared voting and dispositive power. This matters to investors because a significant institutional investor has exited its position, which could signal a lack of confidence in Organon's future performance or a reallocation of capital elsewhere.

Why It Matters

This filing reveals a major institutional investor, Mawer Investment Management, has sold all its shares in Organon & Co., potentially signaling a bearish outlook or a strategic portfolio shift.

Risk Assessment

Risk Level: medium — The complete divestment by an institutional investor like Mawer could indicate underlying concerns about Organon's future, posing a medium risk to current and prospective shareholders.

Analyst Insight

A smart investor would investigate the reasons behind Mawer Investment Management's complete divestment from Organon & Co. and consider if this signals a broader negative sentiment or fundamental issues before making any investment decisions.

Key Numbers

• 0 — Sole Voting Power (Mawer Investment Management Ltd. now holds zero shares with sole voting power in Organon & Co. as of December 31, 2023.)
• 0 — Shared Voting Power (Mawer Investment Management Ltd. now holds zero shares with shared voting power in Organon & Co. as of December 31, 2023.)
• 0 — Sole Dispositive Power (Mawer Investment Management Ltd. now holds zero shares with sole dispositive power in Organon & Co. as of December 31, 2023.)
• 0 — Shared Dispositive Power (Mawer Investment Management Ltd. now holds zero shares with shared dispositive power in Organon & Co. as of December 31, 2023.)

Key Players & Entities

• Mawer Investment Management Ltd. (company) — the reporting person that divested its shares
• Organon & Co. (company) — the issuer whose shares were divested
• December 31, 2023 (date) — the date of the event requiring the filing
• February 5, 2024 (date) — the filing date of the SC 13G/A
• Canada (company) — place of organization for Mawer Investment Management Ltd.

Forward-Looking Statements

• Organon & Co.'s stock price may experience downward pressure due to the institutional divestment. (Organon & Co.) — medium confidence, target: Q1 2024
• Other institutional investors might re-evaluate their positions in Organon & Co. following Mawer's exit. (Organon & Co.) — low confidence, target: Q2 2024

FAQ

Filing Documents

• ogn13g4q2022.htm (SC 13G/A) — 109KB
• 0000945621-24-000167.txt ( ) — 110KB

From the Filing

SC 13G/A 1 ogn13g4q2022.htm AMENDMENT NO. 1 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Organon & Co. (Name of Issuer) Common Stock (Title of Class of Securities) 68622V106 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. Page 2 of 5 Pages 68622V106 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Mawer Investment Management Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Canada NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.00% (1) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) Investment Advisor (1) Based upon 255,606,461 shares of Common Stock of Organon & Co. (the "Issuer") outstanding as of October 27, 2023 as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 3, 2023. CUSIP No. Page 3 of 5 Pages 68622V106 Item 1. (a) Name of Issuer: Organon & Co. (b) Address of Issuer's Principal Executive Offices: 30 Hudson Street, Floor 33 Jersey City, New Jersey, 07302 Item 2. (a) Name of Persons Filing: Mawer Investment Management Ltd. (b) Address of Principal Business Office or, if none, Residence : 600, 517 – 10th Avenue SW Calgary, Alberta, Canada T2R 0A8 (c) Citizenship: Canada (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 68622V106 Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act. (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940. (e) [X] An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G). (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940. CUSIP No. Page 4 of 5 Pages 68622V106 (j) [ ] A non-U.S. institution in accordance with Section 240.13d-1(b)(1) (ii)(J). (k) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: _____________________________________________ Item 4. (a) Amount Beneficially Owned: 0 (b) Percent of Class: 0.00% (c) Number of Shares as to which the person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or direct the vote: 0 (iii) sole power to dispose or direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: Item 6. Not Applicable CUSIP No. Page 5 of 5 Pages 68622V106 Item 7. Identification and Classification of Subsidiaries Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification: By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 30, 2024 By: /s/ Christian Deckart Name: Christian

View Full Filing

View this SC 13G/A filing on SEC EDGAR